These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7503626)

  • 21. Prolongation of cardiac allograft survival in rats following combination treatment with 2-chloro-2'-deoxyadenosine and cyclosporine: a novel immunosuppressive strategy.
    Nawrocki G; Grieb P; Górski A; Danielewicz R; Rowiński W
    Transplant Proc; 1996 Dec; 28(6):3538-9. PubMed ID: 8962374
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis.
    Janiec K; Wajgt A; Kondera-Anasz Z
    Med Sci Monit; 2001; 7(1):93-8. PubMed ID: 11208501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cladribine: not just another purine analogue?
    Spurgeon S; Yu M; Phillips JD; Epner EM
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1169-81. PubMed ID: 19604118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hairy cell leukemia patients with 2-chloro-2'-deoxyadenosine (2-CdA).
    Komarnicki M; Kaźmierczak M; Hansz J
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):31-2. PubMed ID: 7503630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of patients with hairy cell leukemia with 2-chloro-2'-deoxyadenosine (2-CdA).
    Robak T; Krykowski E; Błasińska-Morawiec M; Urbańska-Ryś H
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):25-9. PubMed ID: 7503629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
    Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cladribine for the treatment of hematologic malignancies.
    Baltz JK; Montello MJ
    Clin Pharm; 1993 Nov; 12(11):805-13; quiz 860-2. PubMed ID: 7903917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cladribine].
    Ogura M
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
    Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
    Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cladribine treatment on beta-2 microglobulin and soluble intercellular adhesion molecule 1 (ICAM-1) in patients with multiple sclerosis.
    Niezgoda A; Losy J; Mehta PD
    Folia Morphol (Warsz); 2001 Aug; 60(3):225-8. PubMed ID: 11552664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antileukemic and Immunosuppressive Properties of 2-Chloro-2'-Deoxyadenosine (2-CdA). Symposium proceedings. Warsaw, Poland, November 23, 1992.
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):1-82. PubMed ID: 7503625
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of the efficacy of a pronucleotide of 2-chloro-2'-deoxyadenosine in deoxycytidine kinase-deficient lymphoma cells.
    Bontemps F; Meier C; Delacauw A; Balzarini J; Galmarini C; van den Neste E
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):997-1000. PubMed ID: 17065053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity.
    Laugel B; Borlat F; Galibert L; Vicari A; Weissert R; Chvatchko Y; Bruniquel D
    J Neuroimmunol; 2011 Dec; 240-241():52-7. PubMed ID: 22035961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cladribine. Ortho Biotech Inc.
    Tortorella C; Rovaris M; Filippi M
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1751-6. PubMed ID: 11892941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cladribine conundrum: deciphering the drug's mechanism of action.
    Hentosh P; Peffley DM
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):75-81. PubMed ID: 19968576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pneumocystis carinii pneumonia during therapy with 2-chlorodeoxyadenosine (2-CDA)].
    Haberthür C; Pless M; Tichelli A; Gratwohl A; Speck B; Betticher DC
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):73-8. PubMed ID: 7905206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-Chloro-2' deoxyadenosine prevents angiopathic changes in cerebral arteries in experimental SAH in rabbits.
    Ryba M; Grieb P; Walski M; Sawicki J; Pastuszko M
    Acta Neurochir (Wien); 1993; 122(1-2):118-21. PubMed ID: 8101419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.